— · —

2344.T (2344.T) Stock

—: 2344.T —

—

Valuation

Metric	Value
Price	—
Market Cap	—
P/E Ratio	—
P/B Ratio	—
P/S Ratio	—
EPS (TTM)	—
52-Week High	$1493.00
52-Week Low	$846.00
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	—
ROA	—
ROCE	—
Gross Margin	—
Operating Margin	—
Net Margin	—
Debt/Equity	—
Current Ratio	—

Latest News

NuScale Power Stock Will Spike 23.7% Over the Next 11 Months According to This Wall Street Analyst Motley Fool · Sep 6, 2026 Defending champion Sabalenka reaches US Open quarter-finals AFP · Sep 6, 2026 Arsenal deliver statement fightback to end Chelsea's flying start AFP · Sep 6, 2026 Minnows Augsburg sink Frankfurt to top Bundesliga table AFP · Sep 6, 2026 Walmart’s bestselling $350 Beats Studio Pro noise-canceling headphones are 57% off TheStreet · Sep 6, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	—
Quick Ratio	—
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
2485.TTear Corporation	$431.00	-0.46%	69.49	$9.59B	4.63%
4331.TTake and Give. Needs Co., Ltd	$820.00	-2.15%	22.70	$12.20B	2.40%
6039.TJapan Animal Referral Medical Center Co., Ltd.	$996.00	-1.39%	15.82	$13.18B	1.27%
6561.THanatour Japan Co., Ltd.	$804.00	-1.95%	7.99	$10.33B	5.10%
7235.TTokyo Radiator Mfg.Co.,Ltd.	$1499.00	-0.99%	7.46	$14.51B	5.14%

About 2344.T

—

2344.T is led by CEO Akihiro Yamada, employs 296 people, headquartered in Hiratsuka, JP, publicly traded since 2002.

Official website: www.heian-group.co.jp

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% ALMR Alamar Biosciences, Inc. $29.20 -7.15% AVLN Avalyn Pharma Inc. $26.20 +6.33%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.